Meso Foundation to Adapt Annual Symposium into Three Additional Regional ...



Rick Kornak provides sharp news and insightful articles for the Mesothelioma Cancer Alliance. Bio "



April 01, 2014

Alexandria, Virginia - After successfully hosting its eleventh annual International Symposium on Malignant Mesothelioma in early March, the Mesothelioma Applied Research Foundation has announced three additional conferences to be held in Philadelphia, Chicago, and San Francisco later this year. The conferences will be held at the University of Pennsylvania, the University of Chicago, and the University of California San Francisco in September, October, and November, respectively.

Similar to the recent symposium, the gatherings will serve as a venue for mesothelioma patients, families, and advocates to receive up-to-date information from guest speakers and renowned specialists. The newly announced conferences will offer a condensed version of the annual three-day symposium, enabling attendees to hear numerous speeches and consort with the mesothelioma community in a single day, rather than having to spend multiple nights away from home.

"Informed and knowledgeable patients generally can make better decisions regarding their treatment and care than those unaware of all options, side-effects, and other considerations," said Mary Hesdorffer, the executive director of the Mesothelioma Applied Research Foundation, usually referred to as the "Meso Foundation."

The only nonprofit organization dedicated to ending the deadly disease, the Meso Foundation provides advocacy, education, and support for the mesothelioma community. Broadening its reach to include the three new regions will help the group in its quest. The three locations will also help minimize travel time and encourage more members of the community to get involved.

Mesothelioma is a type of cancer that can only be contracted through exposure to asbestos. Although asbestos has been banned since the 1970s, approximately 3,000 mesothelioma diagnoses are still made each year. This is because the disease has a lengthy latency period and is difficult to diagnose, causing it to be almost always fatal.

Share your thoughts with us on Facebook





Original Post By: http://ift.tt/1i9hT5q

Source : http://ift.tt/1i9hT5q

No comments:

Post a Comment